| human | Q5 |
| P496 | ORCID iD | 0000-0002-2756-2201 |
| P734 | family name | Torzewski | Q37528926 |
| Torzewski | Q37528926 | ||
| Torzewski | Q37528926 | ||
| P735 | given name | Michael | Q4927524 |
| Michael | Q4927524 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q82861083 | A novel in vitro model for the study of plaque development in atherosclerosis |
| Q33607563 | Animal models of C-reactive protein |
| Q89700426 | ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis |
| Q50955462 | Beyond cholesterol: the enigma of atherosclerosis revisited. |
| Q40729069 | C-reactive protein and arteriosclerosis |
| Q34191416 | C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids |
| Q82334800 | Chronic inflammatory cardiomyopathy of interferon γ-overexpressing transgenic mice is mediated by tumor necrosis factor-α |
| Q36114199 | Combined B, T and NK Cell Deficiency Accelerates Atherosclerosis in BALB/c Mice |
| Q38046391 | Complement and atherosclerosis-united to the point of no return? |
| Q37885264 | Cytogenetic analysis of a malignant triton tumour by comparative genomic hybridization (CGH) and review of the literature |
| Q50707608 | Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. |
| Q42606491 | Diagnostic accuracy of C-reactive protein and white blood cell counts in the early detection of inflammatory complications after open resection of colorectal cancer: a retrospective study of 1,187 patients |
| Q54345645 | Differential effects of heart rate reduction with ivabradine in two models of endothelial dysfunction and oxidative stress. |
| Q48004307 | Digestive vacuole of Plasmodium falciparum released during erythrocyte rupture dually activates complement and coagulation |
| Q34680916 | Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid |
| Q46436257 | Endotoxin accelerates atherosclerosis independent of complement activation |
| Q45042444 | Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis |
| Q36836028 | Enzymatically Modified Low-Density Lipoprotein Is Present in All Stages of Aortic Valve Sclerosis: Implications for Pathogenesis of the Disease |
| Q28180222 | Enzymatically modified LDL induces cathepsin H in human monocytes: potential relevance in early atherogenesis |
| Q47772797 | Enzymatically modified LDL, atherosclerosis and beyond: paving the way to acceptance |
| Q43293052 | Eosinophilic meningitis due to Angiostrongylus cantonensis in Germany |
| Q90062583 | Fibroblasts and Their Pathological Functions in the Fibrosis of Aortic Valve Sclerosis and Atherosclerosis |
| Q24298273 | Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease |
| Q40422793 | Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study |
| Q34389247 | Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in aging. |
| Q39601696 | Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression |
| Q31132267 | Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis |
| Q45991963 | Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. |
| Q36681348 | Initiation and progression of atherosclerosis--enzymatic or oxidative modification of low-density lipoprotein? |
| Q35915997 | Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. |
| Q77985431 | Intracerebral hemorrhages, fibrinolysis, and prostate carcinoma |
| Q33415806 | Investigation of Sudan IV staining areas in aortas of infants and children: possible prelesional stages of atherogenesis |
| Q46259874 | Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis |
| Q45926220 | Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo. |
| Q47873792 | Malarial anemia: digestive vacuole of Plasmodium falciparum mediates complement deposition on bystander cells to provoke hemophagocytosis |
| Q37421153 | Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress |
| Q80543352 | No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice |
| Q31075609 | Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice |
| Q44810016 | Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence |
| Q81607398 | Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity |
| Q45140753 | Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization |
| Q42976945 | Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. |
| Q46513399 | Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? |
| Q60935239 | Role of p38 MAPK in Atherosclerosis and Aortic Valve Sclerosis |
| Q38729821 | Selective p38α MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis |
| Q45855018 | Serum starvation and growth factor receptor expression in vascular smooth muscle cells |
| Q80710222 | Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima |
| Q35067512 | T cell-specific overexpression of TGFß1 fails to influence atherosclerosis in ApoE-deficient mice |
Search more.